GL Pharma Eesti OÜ
GL Pharma Eesti OÜ is a OÜ based in Tallinn, registry code 11333147, status: active. Main activity: Activities of advertising agencies. According to EMTA, turnover for Q3 2026 was €83 977 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 83 977 €above 80% of companiesindustry median 15 274 € · companies in the industry: 2 027
- Revenue · 2025 415 935 €above 92% of companiesindustry median 14 652 € · companies in the industry: 3 983
- Net profit margin · 2025 4.8 %above 44% of companiesindustry median 8.6 % · companies in the industry: 3 053
Taxes and turnover
- Company
- Industry median
Industry: Activities of advertising, market research and public relations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 83 977 | — | 2 545 | — |
| Q2 2026 | 97 471 | — | 2 545 | — |
| Q1 2026 | 109 125 | 2 455 | 2 545 | — |
| Q4 2025 | 106 922 | — | 2 545 | — |
| Q3 2025 | 83 019 | — | 2 545 | — |
| Q2 2025 | 87 623 | 3 574 | 2 828 | — |
| Q1 2025 | -32 946 | 2 426 | 2 516 | — |
| Q4 2024 | 112 231 | — | 2 457 | — |
| Q3 2024 | 116 767 | 2 367 | 2 457 | — |
| Q2 2024 | 61 506 | 2 367 | 2 457 | — |
| Q1 2024 | 178 009 | 2 367 | 2 457 | — |
| Q4 2023 | 136 891 | 2 447 | 2 457 | — |
| Q3 2023 | 26 476 | 6 425 | 6 630 | — |
| Q2 2023 | 30 904 | 5 447 | 5 681 | — |
| Q1 2023 | 87 391 | 15 418 | 15 451 | — |
| Q4 2022 | 65 842 | 6 937 | 6 575 | 1 |
| Q3 2022 | 53 724 | 6 694 | 6 575 | 1 |
| Q2 2022 | 40 120 | 6 734 | 6 575 | 1 |
| Q1 2022 | 54 974 | 7 951 | 7 892 | 1 |
Financials by year
- Company
- Industry median
Industry: Activities of advertising, market research and public relations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Activities of advertising, market research and public relations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Activities of advertising, market research and public relations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Activities of advertising, market research and public relations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 415 935 | 19 817 | 23 940 | 247 388 | 145 181 | 1 |
| 2024 | 211 640 | 10 092 | 59 940 | 316 808 | 125 364 | 1 |
| 2023 | 374 980 | 24 088 | 62 415 | 322 998 | 115 272 | 1 |
| 2022 | 232 768 | 10 560 | 64 628 | 129 913 | 91 184 | 2 |
| 2021 | 196 021 | 8 512 | 66 580 | 98 067 | 80 624 | 2 |
| 2020 | 211 949 | 8 033 | 64 968 | 87 950 | 72 112 | 2 |
| 2019 | 199 839 | 6 851 | 65 048 | 85 520 | 64 079 | 2 |
| 2018 | — | — | — | — | — | 2 |
| 2017 | — | — | — | — | — | 2 |
| 2016 | — | — | — | — | — | 2 |
| 2015 | — | — | — | — | — | 2 |
| 2014 | — | — | — | — | — | 2 |
| 2013 | — | — | — | — | — | 2 |
| 2012 | — | — | — | — | — | 2 |
| 2011 | — | — | — | — | — | 2 |
| 2010 | — | — | — | — | — | 2 |
| 2009 | — | — | — | — | — | 2 |
| 2008 | — | — | — | — | — | 2 |
| 2007 | — | — | — | — | — | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 25 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 1 Jul 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 8 May 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 2 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 6 May 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 19 Jun 2020 | Company’s own | e-Äriregister |
Board
- Vladislavs StrodsBoard member · since 2 Jan 2007
- Allan KulpsonBoard member · since 29 Mar 2023
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- SIA "GL Pharma Riga"Legal person · 40 000 €
Beneficial owners
- Martin BartensteinIndirect ownership · AUT · since 1 Oct 2024
Founders and other persons
- Osaühing Lannacher RigaFounder · 40 000 € · 2 Jan 2007
Related companies
Activities (EMTAK)
- 73111Activities of advertising agencies Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10104935 / 11 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 10104935 / 10 12 May 2023 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 12 May 2023 |
||
| Ä 10104935 / 9 8 May 2023 |
Amendment entry | In force 8 May 2023 |
||
| Ä 10104935 / 8 31 Mar 2023 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 31 Mar 2023 |
||
| Ä 10104935 / 7 29 Mar 2023 |
Amendment entry | In force 29 Mar 2023 |
||
| Ä 10104935 / 6 25 May 2018 |
Amendment entry | In force 25 May 2018 |
||
| Ä 10104935 / 5 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10104935 / 4 3 Jan 2011 |
Amendment entry | In force 3 Jan 2011 |
||
| Ä 10104935 / 3 10 Nov 2010 |
Amendment entry | In force 10 Nov 2010 |
||
| Ä 10104935 / M1 20 Oct 2010 |
Ruling to eliminate deficiencies | In force 20 Oct 2010 |
||
| Ä 104935 / 2 1 Jul 2009 |
Deletion of activities from the registry card | In force 1 Jul 2009 |
||
| Ä 104935 2 Jan 2007 |
First entry | In force 2 Jan 2007 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data